Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.
Animals
Bile Acids and Salts
/ metabolism
Disease Models, Animal
Drugs, Chinese Herbal
/ pharmacology
Gastrointestinal Microbiome
/ drug effects
Lithocholic Acid
/ metabolism
Male
Mice
Mice, Inbred C57BL
NF-kappa B
/ metabolism
Non-alcoholic Fatty Liver Disease
/ drug therapy
Receptors, G-Protein-Coupled
/ genetics
Bile acids
Gut microbiota
Inflammation
Membrane-bound G protein-coupled bile acid receptor 1
Nonalcoholic steatohepatitis
Qiang-Gan formula extract
Journal
Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310
Informations de publication
Date de publication:
10 Aug 2020
10 Aug 2020
Historique:
received:
20
05
2019
revised:
13
04
2020
accepted:
18
04
2020
pubmed:
24
4
2020
medline:
17
2
2021
entrez:
24
4
2020
Statut:
ppublish
Résumé
Qiang-Gan formula is a traditional Chinese medicine formula, which has been widely used in treating liver diseases in China. To investigate the effect of Qiang-Gan formula extract (QGE) on non-alcoholic steatohepatitis (NASH) and its underlying possible mechanisms. The high-performance liquid chromatography finger-print method was used for the quality control of chemical components in QGE. Methionine- and choline-deficient diet-induced NASH mice were administrated with QGE via gavage for four weeks. Phenotypic parameters including liver histological change as well as serum levels of alanine transaminase (ALT), aspartate transaminase (AST) were detected. Bile acid profile in the serum, liver and fecal samples was analyzed by gas chromatography-mass spectrometer technique, and fecal microbiota was detected by 16S rDNA sequencing. Expression of liver G protein-coupled bile acid receptor 1 (TGR5), farnesiod X receptor (FXR), tumor necrosis factor-α (TNF-α), interleukin 1β (IL-1β) as well as molecules in nuclear factor kappa B (NF-κB) pathway was assayed by immunohistochemistry staining, RT-qPCR, or Western blot, respectively. QGE alleviated liver inflammation, reduced serum ALT and AST levels and liver TNF-α and IL-1β expression in NASH mice. It also decreased liver and serum BA concentration and increased fecal lithocholicacid (LCA) production in this animal model. QGE altered the structure of gut microbiota, predominantly increased LCA-producing bacteria Bacteroides and Clostridium in NASH mice. In addition, the expression of liver TGR5 but not FXR was increased, and the molecules in NF-κB pathway were decreased in QGE-treated NASH mice. QGE was effective in preventing NASH, possibly by regulation of gut microbiota-mediated LCA production, promotion of TGR5 expression and suppression of the NF-κB activation.
Identifiants
pubmed: 32325178
pii: S0378-8741(19)31987-7
doi: 10.1016/j.jep.2020.112896
pii:
doi:
Substances chimiques
Bile Acids and Salts
0
Drugs, Chinese Herbal
0
Gpbar1 protein, mouse
0
NF-kappa B
0
Receptors, G-Protein-Coupled
0
qianggan
0
Lithocholic Acid
5QU0I8393U
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112896Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interests for this article.